BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 27059980)

  • 1. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
    Zhang RN; Zheng RD; Mi YQ; Zhou D; Shen F; Chen GY; Zhu CY; Pan Q; Fan JG
    Dig Dis Sci; 2016 Aug; 61(8):2284-2293. PubMed ID: 27059980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population.
    Niu TH; Jiang M; Xin YN; Jiang XJ; Lin ZH; Xuan SY
    World J Gastroenterol; 2014 Apr; 20(13):3655-62. PubMed ID: 24707151
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Xu QY; Li H; Cao HX; Pan Q; Fan JG
    Biomed Res Int; 2020; 2020():8869674. PubMed ID: 33294458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
    Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
    J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOC3rs2854116, PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD: A meta-analysis.
    Tong M; Wang F
    IUBMB Life; 2020 Aug; 72(8):1757-1764. PubMed ID: 32525256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
    Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L
    Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.
    Pan Q; Zhang RN; Wang YQ; Zheng RD; Mi YQ; Liu WB; Shen F; Chen GY; Lu JF; Zhu CY; Zhang SY; Chen YM; Sun WL; Fan JG
    World J Gastroenterol; 2015 Jul; 21(28):8605-14. PubMed ID: 26229402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
    Zhang RN; Shen F; Pan Q; Cao HX; Chen GY; Fan JG
    World J Gastroenterol; 2021 Jul; 27(25):3863-3876. PubMed ID: 34321850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
    Valenti L; Nobili V; Al-Serri A; Rametta R; Leathart JB; Zappa MA; Dongiovanni P; Fracanzani AL; Alterio A; Roviaro G; Daly AK; Fargion S; Day CP
    J Hepatol; 2011 Dec; 55(6):1409-14. PubMed ID: 21777557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms associated with obesity and non-alcoholic fatty liver disease in Asian Indian adolescents.
    Jain V; Kumar A; Ahmad N; Jana M; Kalaivani M; Kumar B; Shastri S; Jain O; Kabra M
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):749-758. PubMed ID: 31216264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
    Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
    BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis.
    Zhang L; You W; Zhang H; Peng R; Zhu Q; Yao A; Li X; Zhou Y; Wang X; Pu L; Wu J
    J Gastroenterol Hepatol; 2015 May; 30(5):821-9. PubMed ID: 25641744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.
    Dai G; Liu P; Li X; Zhou X; He S
    Medicine (Baltimore); 2019 Feb; 98(7):e14324. PubMed ID: 30762732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical activity and sedentary behavior can modulate the effect of the PNPLA3 variant on childhood NAFLD: a case-control study in a Chinese population.
    Wang S; Song J; Shang X; Chawla N; Yang Y; Meng X; Wang H; Ma J
    BMC Med Genet; 2016 Dec; 17(1):90. PubMed ID: 27905898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
    Lin YC; Chang PF; Chang MH; Ni YH
    Am J Clin Nutr; 2014 Apr; 99(4):869-74. PubMed ID: 24477042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
    Zampino R; Coppola N; Cirillo G; Boemio A; Pisaturo M; Marrone A; Macera M; Sagnelli E; Perrone L; Adinolfi LE; Miraglia del Giudice E
    J Viral Hepat; 2013 Aug; 20(8):517-23. PubMed ID: 23808989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
    Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
    Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease.
    Bhatt SP; Nigam P; Misra A; Guleria R; Pandey RM; Pasha MA
    Metab Syndr Relat Disord; 2013 Oct; 11(5):329-35. PubMed ID: 23734760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese: A population-based study.
    Yang H; Chen G; Song C; Li D; Ma Q; Chen G; Li X
    Medicine (Baltimore); 2018 Mar; 97(13):e0272. PubMed ID: 29595690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population.
    Li MR; Zhang SH; Chao K; Liao XH; Yao JY; Chen MH; Zhong BH
    World J Gastroenterol; 2014 Oct; 20(38):14010-7. PubMed ID: 25320541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.